David Rickles

David is a co-founder of Radimmune, a recognized expert in clinical radiation oncology, and a driving force behind the development of radioimmunotherapy targeting centrin-1. He is a clinical instructor at the David Geffin School of Medicine at UCLA, where he also completed his own medical and specialty training.